Pioglitazone Drug Injuries

Pioglitazone is a drug that reduces insulin resistance in the liver and improves blood glucose levels. It’s often marketed as Actos and is prescribed to patients to treat the symptoms of Type 2 diabetes. Drugs containing pioglitazone are linked to the development of serious and even fatal health conditions, such as bladder cancer and congestive heart failure. If you or someone you love was prescribed a drug containing pioglitazone and you developed health problems, the Actos lawyers at Ferrer Poirot Feller Daniel want to help you. Call us today at (888) 485-8844 or fill out a free initial consultation form.

Trademarked Names of Pioglitazone

Pioglitazone is marketed as a treatment for Type 2 diabetes under several names, such as:


Actos is the most commonly-prescribed drug containing pioglitazone. Side effects of Actos include fluid retention, high risk of bone fractures, anemia, and more.


ActosplusMet is a medication that combines pioglitazone and metformin—a drug designed to reduce blood sugar levels. Side effects of metformin include upset stomach, decreased testosterone in men, and lactic acidosis—a buildup of lactic acid in the body.


Duetact is a medication that combines pioglitazone and glimepiride—a drug designed to increase insulin production in the pancreas. Side effects of Duetact may include hypoglycemia, upset stomach, and weight gain.

We Help Actos Victims like You

At Ferrer Poirot Feller Daniel, we know that Actos and other drugs containing pioglitazone can cause serious side effects. That’s why we’re dedicated to fighting for the rights of innocent victims who took those medications and developed life-threatening illnesses. Don’t suffer because of the drug manufacturer’s negligence—contact our Actos side effects lawyers, and let us help you get the money you deserve.

Actos®, ActoplusMet®, and Duetact® are registered trademarks of Takeda Pharmaceutical Company Limited.

This law firm is not associated with, sponsored by, or affiliated with Takeda Pharmaceutical Company Limited.